Credit Agricole’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,620
Closed -$2.86M 681
2022
Q1
$2.86M Hold
16,620
0.05% 226
2021
Q4
$2.69M Hold
16,620
0.04% 218
2021
Q3
$2.48M Hold
16,620
0.05% 220
2021
Q2
$4.07M Buy
+16,620
New +$4.36M 0.08% 170
2014
Q2
Sell
-23,900
Closed -$356K 1579
2014
Q1
$356K Sell
23,900
-2,000
-8% -$30.8K ﹤0.01% 1194
2013
Q4
$379K Buy
+25,900
New +$417K ﹤0.01% 1222

Other funds holding AMED

Credit Agricole's AMED Position: Q2 2022 in Review

Credit Agricole sold out of Amedisys (AMED) in Q2 2022, closing a stake of 16,620 shares — an estimated $2.86M sold.

Credit Agricole first reported a position in AMED in Q4 2013 and held it in 6 quarters. The position peaked at $4.07M in Q2 2021. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Credit Agricole reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Credit Agricole sold 16,620 Amedisys shares in Q2 2022, an estimated $2.86M.
  • Credit Agricole first reported a position in Amedisys in Q4 2013 and held it in 6 quarters.
  • Credit Agricole's Amedisys position peaked at $4.07M in Q2 2021.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Credit Agricole's 13F filing for Q2 2022, filed 8 Aug 2022.